15 found
Order:
Disambiguations
J. J. M. van Delden [12]J. J. van Delden [3]
  1.  29
    Terminal Sedation: Source of a Restless Ethical Debate.J. J. M. van Delden - 2007 - Journal of Medical Ethics 33 (4):187.
    Slow euthanasia or a good palliative intervention?There are many ways in which doctors influence the circumstances and/or the timing of a patient’s death. Some of these are accepted as normal medical practice—for instance, when a disproportional treatment is forgone, others are considered tolerable only under strict conditions or even intolerable, such as non-voluntary active euthanasia. A relatively new phenomenon in the ethical discussion on end-of-life decisions is terminal sedation. Terminal sedation is used in patients with terminal illnesses where normal medical (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   18 citations  
  2.  37
    Dutch Criteria of Due Care for Physician-Assisted Dying in Medical Practice: A Physician Perspective.H. M. Buiting, J. K. M. Gevers, J. A. C. Rietjens, B. D. Onwuteaka-Philipsen, P. J. van der Maas, A. van der Heide & J. J. M. van Delden - 2008 - Journal of Medical Ethics 34 (9):e12-e12.
    Introduction: The Dutch Euthanasia Act states that euthanasia is not punishable if the attending physician acts in accordance with the statutory due care criteria. These criteria hold that: there should be a voluntary and well-considered request, the patient’s suffering should be unbearable and hopeless, the patient should be informed about their situation, there are no reasonable alternatives, an independent physician should be consulted, and the method should be medically and technically appropriate. This study investigates whether physicians experience problems with these (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  3.  45
    The Unfeasibility of Requests for Euthanasia in Advance Directives.J. J. M. van Delden - 2004 - Journal of Medical Ethics 30 (5):447-451.
    In April 2002 a new law regarding euthanasia came into effect in the Netherlands. This law holds that euthanasia remains a criminal offence unless it is performed by a physician who acts according to six specified rules of due care and reports the case to a review committee. The six rules of due care are similar to those of the previous regulation and are largely based on jurisprudence. Completely new, however, is the article concerning a competent patient who has written (...)
    Direct download (9 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  4.  60
    Can We Justify Eliminating Coercive Measures in Psychiatry?E. J. D. Prinsen & J. J. M. van Delden - 2009 - Journal of Medical Ethics 35 (1):69-73.
    The practice of coercive measures in psychiatry is controversial. Although some have suggested that it may be acceptable if patients are a danger to others or to themselves, others committed themselves to eliminate it. Ethical, legal and clinical considerations become more complex when the mental incapacity is temporary and when the coercive measures serve to restore autonomy. We discuss these issues, addressing the conflict between autonomy and beneficence/non-maleficence, human dignity, the experiences of patients and the effects of coercive measures. We (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  5.  32
    The Principle of Respect for Autonomy in the Care of Nursing Home Residents.G. J. van Thiel & J. J. van Delden - 2001 - Nursing Ethics 8 (5):419-431.
    Respect for autonomy is well known as a core element of normative views on good care. Most often it is interpreted in a liberal way, with a focus on independence and self-determination. In this article we argue that this interpretation is too narrow in the context of care in nursing homes. With the aim of developing an alternative view on respect for autonomy in this setting we described four interpretations and investigated the moral intuitions (i.e. moral judgements) of caregivers regarding (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  6.  19
    How and When Does Consent Bias Research?R. H. H. Groenwold, R. van der Graaf & J. J. M. van Delden - 2013 - American Journal of Bioethics 13 (4):46 - 48.
  7.  37
    Medical Decision Making in Scarcity Situations.J. J. M. van Delden - 2004 - Journal of Medical Ethics 30 (2):207-211.
    The issue of the allocation of resources in health care is here to stay. The goal of this study was to explore the views of physicians on several topics that have arisen in the debate on the allocation of scarce resources and to compare these with the views of policy makers. We asked physicians and policy makers to participate in an interview about their practices and opinions concerning factors playing a role in decision making for patients in different age groups. (...)
    Direct download (9 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  8.  34
    Disclosure of Risks and Uncertainties Are Especially Vital in Light of Regenerative Medicine.S. L. Niemansburg, M. G. J. L. Habets, J. J. M. Van Delden & A. L. Bredenoord - 2014 - American Journal of Bioethics 14 (4):14-16.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  9.  40
    Dutch Experience of Monitoring Active Ending of Life for Newborns.H. M. Buiting, M. A. C. Karelse, H. A. A. Brouwers, B. D. Onwuteaka-Philipsen, A. van Der Heide & J. J. M. van Delden - 2010 - Journal of Medical Ethics 36 (4):234-237.
    Introduction In 2007, a national review committee was instituted in The Netherlands to review cases of active ending of life for newborns. It was expected that 15–20 cases would be reported. To date, however, only one case has been reported to this committee. Reporting is essential to obtain societal control and transparency; the possible explanations for this lack of reporting were therefore explored. Methods Data on end-of-life decision-making were scrutinised from Dutch nation-wide studies (1995, 2001 and 2005), before institution of (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  10.  40
    The Justificatory Power of Moral Experience.G. J. M. W. van Thiel & J. J. M. van Delden - 2009 - Journal of Medical Ethics 35 (4):234-237.
    A recurrent issue in the vast amount of literature on reasoning models in ethics is the role and nature of moral intuitions. In this paper, we start from the view that people who work and live in a certain moral practice usually possess specific moral wisdom. If we manage to incorporate their moral intuitions in ethical reasoning, we can arrive at judgements and (modest) theories that grasp a moral experience that generally cannot be found outside the practice. Reflective equilibrium (RE) (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  11.  16
    Slippery Slopes in Flat Countries--A Response.J. J. van Delden - 1999 - Journal of Medical Ethics 25 (1):22-24.
    In response to the paper by Keown and Jochemsen in which the latest empirical data concerning euthanasia and other end-of-life decisions in the Netherlands is discussed, this paper discusses three points. The use of euthanasia in cases in which palliative care was a viable alternative may be taken as proof of a slippery slope. However, it could also be interpreted as an indication of a shift towards more autonomy-based end-of-life decisions. The cases of non-voluntary euthanasia are a serious problem in (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  12. Euthanasia: Not Just for Rich Countries.J. J. M. Van Delden & Margaret P. Battin - 2008 - In Ronald M. Green, Aine Donovan & Steven A. Jauss (eds.), Global Bioethics. Oxford University Press.
     
    Export citation  
     
    Bookmark   1 citation  
  13.  18
    Phase IV Research: Innovation in Need of Ethics.G. J. M. W. van Thiel & J. J. M. van Delden - 2008 - Journal of Medical Ethics 34 (6):415-416.
    Worries about safety of approved drugs have pushed post registration research to become the fastest growing drug research phase. Until recently, phase IV studies were mainly conducted for marketing purposes and run much like a phase III trial—at institutions with experienced investigators and a list of inclusion and exclusion criteria. Innovative phase IV studies involve ordinary physicians in research naïve communities. This brings ethical issues familiar to medical research into clinical practice. As a consequence, individual physicians are challenged to protect (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  14.  29
    Deciding Not to Resuscitate in Dutch Hospitals.J. J. van Delden, P. J. van der Maas, L. Pijnenborg & C. W. Looman - 1993 - Journal of Medical Ethics 19 (4):200-205.
    The use of do not resuscitate (DNR) orders in Dutch hospitals was studied as part of a nationwide study on medical decisions concerning the end of life. DNR decisions are made in 6 per cent of all admissions, and 61 per cent of all in-hospital deaths were preceded by a DNR decision. We found that in only 14 per cent of the cases had the patients been involved in the DNR decision (32 per cent of competent patients). The concept of (...)
    Direct download (10 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  15.  90
    Consent for Medical Device Registries: Commentary on Schofield, B. (2013) The Role of Consent and Individual Autonomy in the PIP Breast Implant Scandal.A. L. Bredenoord, N. A. A. Giesbertz & J. J. M. van Delden - 2013 - Public Health Ethics 6 (2):226-229.
    The clinical introduction of medical devices often occurs with relatively little oversight, regulation and (long-term) follow-up. Some recent controversies underscore the weaknesses of the current regime, such as the complications surrounding the metal-on-metal hip implants and the scandal surrounding the global breast implant scare of silicone implants made by France's Poly Implant Prothese (PIP) Company. The absence of national registries hampered the collection of reliable information on the risks and harms of the PIP breast implants. To warrant long-term safety, a (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark